47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,8 | 1 | 0,4 | -59,8 |
Gross profit (loss) | 1,1 | 2 | 0,5 | -75,3 |
EBITDA | 1,1 | 2 | 0,5 | -77,1 |
Short time liabilities | 2 | 1,2 | 1,9 | 60,7 |
Other operating costs | 0 | 0,2 | 0,2 | 11,5 |
Equity capital | 1,5 | 2,4 | 0,6 | -73 |
Operating profit (EBIT) | 1,1 | 2 | 0,4 | -77,5 |
Assets | 3,5 | 3,5 | 2,6 | -27,4 |
Net profit (loss) | 1,1 | 2 | 0,5 | -75,3 |
Cash | 1,4 | 1,4 | 0,3 | -75,8 |
Net income from sale | 12,7 | 13,5 | 12,1 | -10,4 |
Liabilities and provisions for liabilities | 2 | 1,2 | 1,9 | 66,5 |
Working assets | 3,5 | 3,4 | 2,6 | -25,9 |
Other income costs | 0,3 | 1,1 | 0,2 | -78,7 |
Depreciation | 0 | 0 | 0 | -28,5 |
% | % | % | p.p. | |
Profitability of capital | 73,2 | 83,2 | 76,1 | -7,1 |
Equity capital to total assets | 42,3 | 67,3 | 25 | -42,3 |
Gross profit margin | 8,6 | 14,7 | 4 | -10,7 |
EBITDA Margin | 8,7 | 14,8 | 3,8 | -11 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 57 | 31 | 56 | 25 |
Current financial liquidity indicator | 1.7807044982910156 | 2.979093551635742 | 1.373046875 | -1,6 |
Net dept to EBITDA | -1.1315113306045532 | -0.6901596784591675 | -0.7636303901672363 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane